Adeno-to-squamous transition drives resistance to KRAS inhibition in LKB1 mutant lung cancer
Xinyuan Tong(Chinese Academy of Sciences), Hongbin Ji(Westlake University), Kevin S. Kapner(Broad Institute), Luonan Chen(Shanghai Jiao Tong University), Laura D. Hover, Fiona Sherman(NYU Langone Health), Kwok‐Kin Wong(NYU Langone Health), Itai Yanai(NYU Langone Health), Priyanka Sahu(NYU Langone Health), Eejung Kim(Broad Institute), Satrajit Sinha(University at Buffalo, State University of New York), Minglei Shi(Peking University), Ayushi S. Patel(Icahn School of Medicine at Mount Sinai), Julien Dilly(Massachusetts Institute of Technology), Yueqing Chen(Center for Excellence in Molecular Cell Science), André L. Moreira(NYU Langone Health), Suman Mukhopadhyay(NYU Langone Health), Dong Gao(Shenzhen Bay Laboratory), Khrystyna Myndzar(NYU Langone Health), Zhaoyuan Fang(Second Affiliated Hospital of Zhejiang University), Michael Q. Zhang(The University of Texas at Dallas), Thian Kheoh(Janssen (United States)), Wenjing Yang(Chinese Academy of Medical Sciences & Peking Union Medical College), Benjamin G. Neel(New York University), Yun Xue(Chinese Academy of Sciences), Vamsidhar Velcheti(Cleveland Clinic), Yijun Gao(Sun Yat-sen University), James G. Christensen, Andrew J. Aguirre(Broad Institute), Ningxia Zhang(Zhejiang University), Yujuan Jin(Chinese Academy of Sciences), Fei Li(Chinese Academy of Sciences), Yang Chen(RE Hydrogen (United Kingdom)), Shuai Li(NYU Langone Health), Hongjun Li(Tsinghua University), Liang Hu(Ministry of Agriculture and Rural Affairs), Fuming Li(Fudan University), Juntao Gao(Bioinformatics Institute), Shengwu Liu(Broad Institute), Peter Olson(University of New Mexico)
Cited by 115
Related Papers
<i>MET</i> Amplification Leads to Gefitinib Resistance in Lung Cancer by Activating ERBB3 Signaling
|Science|2007|4.5k
Abiraterone in Metastatic Prostate Cancer without Previous Chemotherapy
|New England Journal of Medicine|2012|2.8k
Dependency of a therapy-resistant state of cancer cells on a lipid peroxidase pathway
|Nature|2017|2k
Sotorasib for Lung Cancers with <i>KRAS</i> p.G12C Mutation
|New England Journal of Medicine|2021|1.8k